Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Effect of Electroacupuncture on Bowel Function and Quality of Life in Postpartum Constipation: A Randomized Controlled Trial

1 mei 2026 bijgewerkt door: shaimaa Mohamed hamed, MTI University
Postpartum constipation is a common condition affecting women after childbirth, leading to discomfort and reduced quality of life. Pharmacological treatments may have side effects and are sometimes avoided during breastfeeding. Electroacupuncture is a safe, non-pharmacological intervention that may improve bowel motility. However, limited evidence exists regarding its effectiveness in postpartum women, necessitating further investigation

Studie Overzicht

Toestand

Nog niet aan het werven

Gedetailleerde beschrijving

to evaluate the effect of electroacupuncture on improving bowel function and reducing symptoms of postpartum constipation compared to standard care.

Study population & Sample size: (no more than 3 lines) Postpartum women aged 20-40 years diagnosed with constipation. A randomized controlled trial with two parallel groups: an electroacupuncture group and a control group receiving abdominal exercises . Participants will be randomly assigned using a simple randomization method.

Diagnosis:

Postpartum constipation diagnosed based on clinical criteria (e.g., Rome IV criteria).

Groups:

  • Group A: Electroacupuncture + abdominal exercises
  • Group B: abdominal exercises only

Inclusion Criteria:

  • Females aged 20-40 years
  • Within 6 weeks postpartum
  • Diagnosed with constipation
  • Willing to participate

Exclusion Criteria:

  • History of gastrointestinal disorders
  • Previous colorectal surgery
  • Neurological diseases affecting bowel function
  • Contraindications to acupuncture (tumor, scar or keloids & spinal instability ).

Measuring Tools:

  1. Bristol Stool Form Scale This scale will be used to assess stool consistency, which is classified into seven distinct types ranging from hard lumps to entirely liquid stool. It is considered an important indicator of intestinal transit time. The Bristol Stool Form Scale is widely validated and demonstrates high reliability and reproducibility in clinical and research settings. In this study, it will be used as a primary outcome measure to evaluate changes in bowel habits, either independently or alongside bowel movement frequency.
  2. Patient Assessment of Constipation Quality of Life (PAC-QOL) This questionnaire will be used to evaluate the impact of constipation on patients' daily life, including physical discomfort, psychosocial effects, and overall satisfaction. The PAC-QOL has excellent psychometric properties, including strong validity and reliability. In this study, it will be used as a secondary outcome measure to assess improvements in quality of life following the intervention.

    • Evaluation procedures All participants will undergo a standardized evaluation before and after the intervention period. Baseline assessment will be conducted prior to randomization to ensure comparability between groups.

At the beginning of the study, demographic and clinical data will be collected, including age, parity, mode of delivery, and time since delivery. Participants will then be evaluated for constipation severity and bowel habits.

Stool consistency will be assessed using the Bristol Stool Form Scale, where participants will classify their stool type according to the seven-point scale. In addition, participants will be instructed to record bowel movement frequency per week using a bowel diary.

Quality of life related to constipation will be evaluated using the Patient Assessment of Constipation Quality of Life (PAC-QOL) questionnaire. This tool will assess the physical, psychological, and social impact of constipation on daily living.

All outcome measures will be recorded at baseline (pre-treatment) and at the end of the treatment period (post-treatment). Participants will also be monitored throughout the study to ensure compliance and to document any adverse effects.

• Treatment procedures The electroacupuncture group will receive treatment sessions 3 times per week for 6 weeks using Quchi (LI11) and Shangjuxu (ST37) acupoints added to abdominal exercises . The control group will receive abdominal exercises only.

Studietype

Ingrijpend

Inschrijving (Geschat)

60

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Volwassen

Accepteert gezonde vrijwilligers

Ja

Beschrijving

Inclusion Criteria:

  • Females aged 20-40 years
  • Within 6 weeks postpartum
  • Diagnosed with constipation
  • Willing to participate

Exclusion Criteria:

  • History of gastrointestinal disorders
  • Previous colorectal surgery
  • Neurological diseases affecting bowel function
  • Contraindications to acupuncture (tumor, scar or keloids & spinal instability ).

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Enkel

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: electro acupuncture group
Participants in this group will receive electroacupuncture therapy applied to Quchi (LI11) and Shangjuxu (ST37) acupoints plus abdominal exercises Treatment will be administered [12 sessions per week] for [6 weeks], with each session lasting approximately [30 minutes]. The intervention aims to improve bowel function in postpartum constipation.

This study is expected to contribute significantly to maternal healthcare in Egypt by addressing postpartum constipation, a common yet often neglected condition affecting women after childbirth. Constipation can negatively impact quality of life, causing discomfort, pain, and psychological distress.

Electroacupuncture offers a safe, non-pharmacological, and cost-effective treatment alternative. This is particularly important for postpartum women who may avoid medications due to breastfeeding concerns or side effects.

The findings of this study may support the integration of electroacupuncture into routine postpartum care in Egypt, especially within physical therapy and rehabilitation programs. It may also help reduce dependence on laxatives and improve patient satisfaction.

Static Abdominal Contractions Lie on your back in "crook lying" (knees bent, feet flat). Gently contract all abdominal muscles (as if bracing for a light punch), hold 5-10 seconds, then release. Repeat. Keep breathing normally. This strengthens the abdominal wall to improve bowel support and tone.

Activation and exercise of the transverse abdominis muscle has been noted as important, as it brings together the bellies of the rectus abdominus muscle, improving the integrity of the linea alba and increasing fascial tension. While studied primarily for diastasis recti, these exercises engage the deep core and can support improved abdominal function overall.

Actieve vergelijker: control group
Participants in this group will perform a structured abdominal exercise program designed to improve bowel motility. Exercises will be conducted [12 sessions per week] for [6 weeks], with each session lasting approximately [20 minutes].

Static Abdominal Contractions Lie on your back in "crook lying" (knees bent, feet flat). Gently contract all abdominal muscles (as if bracing for a light punch), hold 5-10 seconds, then release. Repeat. Keep breathing normally. This strengthens the abdominal wall to improve bowel support and tone.

Activation and exercise of the transverse abdominis muscle has been noted as important, as it brings together the bellies of the rectus abdominus muscle, improving the integrity of the linea alba and increasing fascial tension. While studied primarily for diastasis recti, these exercises engage the deep core and can support improved abdominal function overall.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Bristol Stool Form Scale
Tijdsspanne: 6 weeks
This scale will be used to assess stool consistency, which is classified into seven distinct types ranging from hard lumps to entirely liquid stool. It is considered an important indicator of intestinal transit time. The Bristol Stool Form Scale is widely validated and demonstrates high reliability and reproducibility in clinical and research settings. In this study, it will be used as a primary outcome measure to evaluate changes in bowel habits, either independently or alongside bowel movement frequency.
6 weeks
Patient Assessment of Constipation Quality of Life (PAC-QOL)
Tijdsspanne: 6 weeks
This questionnaire will be used to evaluate the impact of constipation on patients' daily life, including physical discomfort, psychosocial effects, and overall satisfaction. The PAC-QOL has excellent psychometric properties, including strong validity and reliability. In this study, it will be used as a secondary outcome measure to assess improvements in quality of life following the intervention.
6 weeks

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Sponsor

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

20 mei 2026

Primaire voltooiing (Geschat)

20 augustus 2026

Studie voltooiing (Geschat)

20 oktober 2026

Studieregistratiedata

Eerst ingediend

1 mei 2026

Eerst ingediend dat voldeed aan de QC-criteria

1 mei 2026

Eerst geplaatst (Werkelijk)

7 mei 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

7 mei 2026

Laatste update ingediend die voldeed aan QC-criteria

1 mei 2026

Laatst geverifieerd

1 mei 2026

Meer informatie

Termen gerelateerd aan deze studie

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren